Back

Soluble programed cell death ligand-1 is associated with acute coronary syndrome

8 November 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 1 Biomarkers ESC Premium Access ESC Asia with APSC & AFC

About the speaker

Photo
Doctor Koichiro Fujisue

Kumamoto University, Kumamoto (Japan)

32 More presentations in this session

Presentation thumbnail
Clinical utility of stress echocardiography in remote indigenous and non-indigenous populations: a 10-year study in central Australia
Doctor S. Ratwatte (London, GB)
Abstract
Presentation thumbnail
Characterisation of right heart dysfunction in left ventricular systolic failure
Doctor H. Chen (Sydney, AU)
Abstract
Presentation thumbnail
The impact of coronary calcification on diagnostic performance of workstation CT derived fractional flow reserve - a multicentre experience
Ms M. Isa (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Efficacy and safety of catheter ablation combined with left atrial appendage occlusion in patients with atrial fibrillation over one year: first results in a Chinese population
Mr F. Xiao (Wenzhou, CN)
Presentation thumbnail
Novel use of CHA2DS2VASC score to select patients to undergo repeat atrial fibrillation screening
Doctor W. Sun (Shatin, HK)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1

The Event

Event poster

ESC Asia with APSC & AFC

8 November 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
High plasma levels of soluble LOX-1 portends poor survival in acute coronary syndromes beyond GRACE 2.0: A multicentre prospective cohort study
27 August 2021
thumbnail
Congress Presentation
Checkpoint nano-degrader to transiently promote efferocytosis in acute myocardial infarction
25 August 2023
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
13 October 2025
thumbnail
Congress Presentation
Circulating LIGHT/TNFSF14 levels are negatively associated with cardiovascular mortality, while intra-plaque levels are associated with symptomatic cerebrovascular disease
13 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources